TBT - New Position

A new CSP position was established today on ProShares UltraShort 20+ Year Treasury (TBT). All prices include IB commissions.

This is the third position on TBT.

This position represents a new strategy for idle cash. The idea is to earn interest at the current 30 Year Treasury rate (3.12%) or more for a period of 1 year or less. I chose the lowest possible strike and shortest expiration that met the criteria. The 14 strike provides 25% downside protection at the current price through Jan 2013, and is 20% below the 52 week low of $17.28, which also happens to be the lowest close since inception. With interest rates at historic lows, and unlikely to go much lower, this seems like a pretty safe bet and it beats leaving cash in the account at zero interest.

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/25/2012	TBT	CSP Margin Used	CSP 400 TBT @ 14.00		($5,600.00)
1/25/2012	TBT	Initial Put Option	STO 4 Jan13 14.00 Put @ 0.57			$229.70

Position Summary

Cost Basis	($5,600.00)
Income Generated	$229.70
Percent Income Generated	4.10%
Annualized Income Generated	4.17%
Net Profit If Assigned	$229.70
Percent Return If Assigned	4.10%
Annualized Return If Assigned	4.17%
Days Held to Expiration	359 days

NVS - New Position

A new CSP position was established today on Novartis (NVS). All prices include IB commissions.

Criteria	Value
Dividend Champions Status	Contender
Years of Consecutive Dividend Increases	10
Fair Value Estimate	$71.00
Target Buy Price	$56.80
Target Margin of Safety	20.00%
Actual Buy Price	$52.50
Actual Margin of Safety	26.06%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/25/2012	NVS	CSP Margin Used	CSP 100 NVS @ 52.50		($5,250.00)
1/25/2012	NVS	Initial Put Option	STO 1 Mar12 52.50 Put @ 1.18			$117.97

Position Summary

Cost Basis	($5,250.00)
Income Generated	$117.97
Percent Income Generated	2.25%
Annualized Income Generated	16.08%
Net Profit If Assigned	$117.97
Percent Return If Assigned	2.25%
Annualized Return If Assigned	16.08%
Days Held to Expiration	51 days

COP - New Position

A new CSP position was established today on ConocoPhillips (COP). All prices include IB commissions.

Criteria	Value
Dividend Champions Status	Contender
Years of Consecutive Dividend Increases	11
Fair Value Estimate	$85.00
Target Buy Price	$68.00
Target Margin of Safety	20.00%
Actual Buy Price	$67.50
Actual Margin of Safety	20.59%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/25/2012	COP	CSP Margin Used	CSP 100 COP @ 67.50		($6,750.00)
1/25/2012	COP	Initial Put Option	STO 1 Mar12 67.50 Put @ 1.31			$130.97

Position Summary

Cost Basis	($6,750.00)
Income Generated	$130.97
Percent Income Generated	1.94%
Annualized Income Generated	13.89%
Net Profit If Assigned	$130.97
Percent Return If Assigned	1.94%
Annualized Return If Assigned	13.89%
Days Held to Expiration	51 days

ABT - New Position

A new CSP position was established today on Abbott Laboratories (ABT). All prices include IB commissions.

This is the second position on ABT.

Criteria	Value
Dividend Champions Status	Champion
Years of Consecutive Dividend Increases	39
Years of Positive Free Cash Flow (last 10 years)	10
Fair Value Estimate	$68.00
Target Buy Price	$54.40
Target Margin of Safety	20.00%
Actual Buy Price	$52.50
Actual Margin of Safety	22.79%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/25/2012	ABT	CSP Margin Used	CSP 100 ABT @ 52.50		($5,250.00)
1/25/2012	ABT	Initial Put Option	STO 1 May12 52.50 Put @ 1.00			$100.12

Position Summary

Cost Basis	($5,250.00)
Income Generated	$100.12
Percent Income Generated	1.91%
Annualized Income Generated	6.11%
Net Profit If Assigned	$100.12
Percent Return If Assigned	1.91%
Annualized Return If Assigned	6.11%
Days Held to Expiration	114 days

SPY - New Position

A new CSP position was established today on SPDR S&P 500 ETF (SPY). All prices include IB commissions.

This position represents a new strategy for idle cash. The idea is to earn interest at the current 10 Year Treasury rate (2.05%) or more for a period of 1 year or less. I chose the lowest possible strike and shortest expiration that met the criteria. The 85 strike provides 35% downside protection at the current price through Dec 2012, and is at a multi-year support level. This seems like a pretty safe bet and it beats leaving cash in the account at zero interest.

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/24/2012	SPY	CSP Margin Used	CSP 100 SPY @ 85.00		($8,500.00)
1/24/2012	SPY	Initial Put Option	STO 1 Dec12 85.00 Put @ 1.63			$162.97

Position Summary

Cost Basis	($8,500.00)
Income Generated	$162.97
Percent Income Generated	1.92%
Annualized Income Generated	2.11%
Net Profit If Assigned	$162.97
Percent Return If Assigned	1.92%
Annualized Return If Assigned	2.11%
Days Held to Expiration	332 days

BHP - New Position

A new CSP position was established today on BHP Billiton Ltd. (BHP). All prices include IB commissions.

Criteria	Value
Dividend Champions Status	Challenger
Years of Consecutive Dividend Increases	9
Fair Value Estimate	$100.00
Target Buy Price	$70.00
Target Margin of Safety	30.00%
Actual Buy Price	$70.00
Actual Margin of Safety	30.00%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/24/2012	BHP	CSP Margin Used	CSP 100 BHP @ 70.00		($7,000.00)
1/24/2012	BHP	Initial Put Option	STO 1 Feb12 70.00 Put @ 0.46			$45.97

Position Summary

Cost Basis	($7,000.00)
Income Generated	$45.97
Percent Income Generated	0.66%
Annualized Income Generated	9.99%
Net Profit If Assigned	$45.97
Percent Return If Assigned	0.66%
Annualized Return If Assigned	9.99%
Days Held to Expiration	24 days

BDX - Adjustment

The following adjustment was made today on Becton Dickinson and Company (BDX). All prices include IB commissions.

Criteria	Value
Dividend Champions Status	Champion
Years of Consecutive Dividend Increases	38
Fair Value Estimate	$98.00
Target Buy Price	$80.00
Target Margin of Safety	18.37%
Actual Buy Price	$80.00
Actual Margin of Safety	18.37%

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
1/24/2012	BDX	Continued Trade	STO 1 Feb12 80.00 Call @ 0.76			$76.27

Current Position Summary

Cost Basis	($8,000.00)
Income Generated	$442.97
Percent Income Generated	5.54%
Annualized Income Generated	7.49%
Net Profit If Assigned	$442.97
Percent Return If Assigned	5.54%
Annualized Return If Assigned	7.49%
Days Held to Expiration	270 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
5/23/2011	BDX	CSP Margin Used	CSP 100 BDX @ 80.00		($8,000.00)
5/23/2011	BDX	Initial Put Option	STO 1 Sep11 80.00 Put @ 1.44	Exercised		$143.98
9/16/2011	BDX	CSP Margin Returned	CSP 100 BDX @ -80.00		$8,000.00
9/16/2011	BDX	Stock Assigned	EX 1 Sep11 80.00 Put @ -80.00		($8,000.00)
9/27/2011	BDX	Continued Trade	STO 1 Nov11 80.00 Call @ 1.78	Expired		$177.72
12/30/2011	BDX	Dividend Received	DIV 100 Dividend @ 0.45			$45.00
1/24/2012	BDX	Continued Trade	STO 1 Feb12 80.00 Call @ 0.76			$76.27
2/17/2012	BDX		Totals		($8,000.00)	$442.97
DTE	270		Percent Income/Annualized		5.54%	7.49%

XOM - Closed

The Exxon Mobil Corp (XOM) Jan12 67.50 Put expired and the position was closed. All prices include IB commissions.

Closed Position Summary

Cost Basis	$6,750.00
Net Profit	$171.17
Percent Return	2.54%
Annualized Return	11.57%
Days Held to Expiration	80 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
11/1/2011	XOM	CSP Margin Used	CSP 100 XOM @ 67.50		($6,750.00)
11/1/2011	XOM	Initial Put Option	STO 1 Jan12 67.50 Put @ 1.71	Expired		$171.17
1/20/2012	XOM	CSP Margin Returned	CSP 100 XOM @ -67.50			$6,750.00
1/20/2012	XOM		Net Cost/Profit-Loss		($6,750.00)	$171.17
DTE	80		Percent Profit-Loss/Annualized		2.54%	11.57%

TEVA - Closed

The Teva Pharmaceutical Industries Ltd (TEVA) Jan12 35.00 Put expired and the position was closed. All prices include IB commissions.

Position Summary

Cost Basis	$3,500.00
Net Profit	$100.98
Percent Return	2.89%
Annualized Return	18.16%
Days Held to Expiration	58 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
11/23/2011	TEVA	CSP Margin Used	CSP 100 TEVA @ 35.00		($3,500.00)
11/23/2011	TEVA	Initial Put Option	STO 1 Jan12 35.00 Put @ 1.01	Expired		$100.98
1/20/2012	TEVA	CSP Margin Returned	CSP 100 TEVA @ -35.00			$3,500.00
1/20/2012	TEVA		Net Cost/Profit-Loss		($3,500.00)	$100.98
DTE	58		Percent Profit-Loss/Annualized		2.89%	18.16%

TEVA - Closed

The Teva Pharmaceutical Industries Ltd (TEVA) Jan12 45.00 Call was exercised and the position was closed. All prices include IB commissions.

Position Summary

Cost Basis	$4,500.00
Net Profit	$231.21
Percent Return	5.14%
Annualized Return	7.75%
Days Held to Expiration	242 days

Trade History

Date	Stock	Description	Transaction	Status	Stock Investment	Income Generated
5/23/2011	TEVA	CSP Margin Used	CSP 100 TEVA @ 45.00		($4,500.00)
5/23/2011	TEVA	Initial Put Option	STO 1 Sep11 45.00 Put @ 1.23	Exercised		$122.98
9/16/2011	TEVA	CSP Margin Returned	CSP 100 TEVA @ -45.00		$4,500.00
9/16/2011	TEVA	Stock Assigned	EX 1 Sep11 45.00 Put @ -45.00		($4,500.00)
11/3/2011	TEVA	Continued Trade	STO 1 Jan12 45.00 Call @ 0.91	Exercised		$91.13
12/7/2011	TEVA	Dividend Received	DIV 100 Dividend @ 0.21			$21.49
12/7/2011	TEVA	Withholding Tax	TAX 1 Tax @ -0.04			($4.30)
1/20/2012	TEVA	Stock Called	EX 1 Jan12 45.00 Call @ 45.00			$4,499.91
1/20/2012	TEVA		Net Cost/Profit-Loss		($4,500.00)	$231.21
DTE	242		Percent Profit-Loss/Annualized		5.14%	7.75%